AGIO (STOCKS)
Agios Pharmaceuticals, Inc.
$33.150000
+0.230000 (+0.70%)
Prev close: $32.920000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Brian M. Goff
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,941.75M
- Employees
- 488
- P/E (TTM)
- -4.62
- P/B (TTM)
- 1.61
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
7
Buy
4
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-1.86 | $-1.99 | +0.1252 | +6.31% |
|
Sep 2025 (Q3)
|
$-1.78 | $-1.94 | +0.1567 | +8.09% |
|
Jun 2025 (Q2)
|
$-1.93 | $-1.84 | -0.0863 | -4.68% |
|
Mar 2025 (Q1)
|
$-1.55 | $-1.82 | +0.2694 | +14.81% |
Financial Statements
| Revenues | $54.03M |
| Benefits Costs and Expenses | $467.83M |
| Cost Of Revenue | $6.35M |
| Costs And Expenses | $526.16M |
| Gross Profit | $47.68M |
| Operating Expenses | $519.82M |
| Selling, General, and Administrative Expenses | $180.28M |
| Research and Development | $339.54M |
| Operating Income/Loss | -$472.13M |
| Income/Loss From Continuing Operations After Tax | -$412.78M |
| Income/Loss From Continuing Operations Before Tax | -$413.80M |
| Income Tax Expense/Benefit | -$1.02M |
| Net Income/Loss | -$412.78M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$412.78M |
| Net Income/Loss Available To Common Stockholders, Basic | -$412.78M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$7.12 |
| Diluted Earnings Per Share | -$7.12 |
| Basic Average Shares | 57,972,004 |
| Diluted Average Shares | 57,972,004 |
| Assets | $1.30B |
| Current Assets | $942.05M |
| Cash | $1.20B |
| Inventory | $32.92M |
| Noncurrent Assets | $355.17M |
| Fixed Assets | $10.78M |
| Other Non-current Assets | $344.40M |
| Liabilities | $104.11M |
| Current Liabilities | $82.21M |
| Accounts Payable | $18.36M |
| Wages | $27.26M |
| Other Current Liabilities | $36.59M |
| Noncurrent Liabilities | $21.91M |
| Equity | $1.19B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.19B |
| Liabilities And Equity | $1.30B |
| Net Cash Flow From Operating Activities | -$372.98M |
| Net Cash Flow From Operating Activities, Continuing | -$372.98M |
| Net Cash Flow From Investing Activities | $377.18M |
| Net Cash Flow From Investing Activities, Continuing | $377.18M |
| Net Cash Flow From Financing Activities | $8.68M |
| Net Cash Flow From Financing Activities, Continuing | $8.68M |
| Net Cash Flow | $12.88M |
| Net Cash Flow, Continuing | $12.88M |
| Comprehensive Income/Loss | -$409.07M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$409.07M |
| Other Comprehensive Income/Loss | -$409.07M |